4,809 Shares in Fresenius Medical Care Corporation (NYSE:FMS) Acquired by Park Avenue Securities LLC

Park Avenue Securities LLC purchased a new position in Fresenius Medical Care Corporation (NYSE:FMS) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,809 shares of the company’s stock, valued at approximately $234,000.

Several other institutional investors have also recently bought and sold shares of the company. Harding Loevner LP raised its position in Fresenius Medical Care Corporation by 7.1% in the first quarter. Harding Loevner LP now owns 3,528,960 shares of the company’s stock worth $148,675,000 after buying an additional 233,347 shares during the last quarter. Cambiar Investors LLC raised its position in Fresenius Medical Care Corporation by 8.1% in the first quarter. Cambiar Investors LLC now owns 2,516,416 shares of the company’s stock worth $106,017,000 after buying an additional 188,019 shares during the last quarter. Karp Capital Management Corp purchased a new position in Fresenius Medical Care Corporation during the first quarter worth $7,887,000. Renaissance Technologies LLC purchased a new position in Fresenius Medical Care Corporation during the first quarter worth $7,141,000. Finally, Bank of America Corp DE raised its position in Fresenius Medical Care Corporation by 12.1% in the first quarter. Bank of America Corp DE now owns 1,493,411 shares of the company’s stock worth $62,917,000 after buying an additional 161,262 shares during the last quarter. Institutional investors and hedge funds own 2.81% of the company’s stock.

Fresenius Medical Care Corporation (NYSE FMS) opened at 46.38 on Friday. The company’s 50 day moving average is $47.31 and its 200-day moving average is $44.97. The company has a market cap of $28.46 billion, a price-to-earnings ratio of 20.25 and a beta of 0.47. Fresenius Medical Care Corporation has a 12 month low of $38.05 and a 12 month high of $50.22.

Fresenius Medical Care Corporation (NYSE:FMS) last released its earnings results on Tuesday, August 1st. The company reported $0.48 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.53 by $0.05. Fresenius Medical Care Corporation had a return on equity of 11.57% and a net margin of 7.06%. The firm had revenue of $4.47 billion for the quarter, compared to analysts’ expectations of $5.20 billion. During the same quarter in the previous year, the company posted $0.96 earnings per share. The firm’s quarterly revenue was up 11.1% on a year-over-year basis. On average, analysts expect that Fresenius Medical Care Corporation will post $2.33 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “4,809 Shares in Fresenius Medical Care Corporation (NYSE:FMS) Acquired by Park Avenue Securities LLC” was first posted by BNB Daily and is the property of of BNB Daily. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/08/19/park-avenue-securities-llc-purchases-new-stake-in-fresenius-medical-care-corporation-nysefms-updated-updated.html.

FMS has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded shares of Fresenius Medical Care Corporation from a “hold” rating to a “buy” rating and set a $49.00 price target for the company in a research report on Tuesday, April 25th. DZ Bank AG reiterated a “neutral” rating on shares of Fresenius Medical Care Corporation in a research report on Saturday, May 20th. BidaskClub lowered shares of Fresenius Medical Care Corporation from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Nord/LB reiterated a “buy” rating on shares of Fresenius Medical Care Corporation in a research report on Wednesday, June 28th. Finally, Royal Bank Of Canada reiterated a “hold” rating and issued a $44.00 price target on shares of Fresenius Medical Care Corporation in a research report on Wednesday, July 5th. One analyst has rated the stock with a sell rating, five have given a hold rating and seven have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $48.67.

Fresenius Medical Care Corporation Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Institutional Ownership by Quarter for Fresenius Medical Care Corporation (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply